Everence Capital Management’s Omnicell OMCL Stock Holding History

Everence Capital Management’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,710	Closed	-$249K	–	971
2024 Q3	$249K	Buy	+5,710	New	+$215K	0.02%	656
2022 Q3	–	Sell	-6,130	Closed	-$697K	–	743
2022 Q2	$697K	Hold	6,130	–	–	0.06%	252
2022 Q1	$794K	Hold	6,130	–	–	0.06%	256
2021 Q4	$1.11M	Hold	6,130	–	–	0.08%	207
2021 Q3	$910K	Hold	6,130	–	–	0.07%	218
2021 Q2	$928K	Hold	6,130	–	–	0.08%	215
2021 Q1	$796K	Sell	6,130 -970	-14%	-$124K	0.07%	223
2020 Q4	$852K	Sell	7,100 -940	-12%	-$92.2K	0.08%	200
2020 Q3	$600K	Hold	8,040	–	–	0.07%	239
2020 Q2	$538K	Hold	8,040	–	–	0.06%	271
2020 Q1	$527K	Buy	8,040 +2,330	+41%	+$186K	0.07%	225
2019 Q4	$467K	Hold	5,710	–	–	0.07%	302
2019 Q3	$413K	Hold	5,710	–	–	0.07%	320
2019 Q2	$491K	Hold	5,710	–	–	0.08%	263
2019 Q1	$462K	Buy	+5,710	New	+$427K	0.08%	271
2018 Q4	–	Sell	-2,840	Closed	-$204K	–	440
2018 Q3	$204K	Buy	+2,840	New	+$179K	0.04%	408

Other funds holding OMCL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Everence Capital Management's OMCL Position: Q4 2024 in Review

Everence Capital Management sold out of Omnicell (OMCL) in Q4 2024, closing a stake of 5,710 shares — an estimated $249K sold.

Everence Capital Management first reported a position in OMCL in Q3 2018 and held it in 16 quarters. The position peaked at $1.11M in Q4 2021. 279 funds tracked by Wall St. Rank hold OMCL as of Q4 2024.

Everence Capital Management reported no remaining Omnicell position as of Q4 2024 after selling out during the quarter.
Everence Capital Management sold 5,710 Omnicell shares in Q4 2024, an estimated $249K.
Everence Capital Management first reported a position in Omnicell in Q3 2018 and held it in 16 quarters.
Everence Capital Management's Omnicell position peaked at $1.11M in Q4 2021.
279 funds tracked by Wall St. Rank held Omnicell as of Q4 2024.

Based on Everence Capital Management's 13F filing for Q4 2024, filed 3 Jan 2025.